Cognitive, Affective, and Motor Effects of Tangotherapy in Parkinson's Disease
NCT05904171, Not applicable, Completed, Istituto Auxologico Italiano
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Cognitive, Affective, and Motor Effects of Tangotherapy in Parkinson's Disease | ClinicalTrials.gov |
| NCT number | NCT05904171 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 45 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Istituto Auxologico Italiano | ClinicalTrials.gov |
| Conditions | Parkinson Disease | ClinicalTrials.gov |
| Interventions | Tangotherapy, Physical activity | ClinicalTrials.gov |
| First posted | 2023-06-15 | ClinicalTrials.gov |
| Last updated | 2025-09-03 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Parkinson's Disease Cognitive Rating Scale (PD-CRS) - total score | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A battery of cognitive tests of memory, selective attention, visuo-spatial skills, and flexibility. | ClinicalTrials.gov |
| Primary | Change in Hospital Anxiety and Depression Scale (HADS) - total score | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A scale assessing depressive and anxiety symptoms. | ClinicalTrials.gov |
| Primary | Change in Health-related quality of Life (EQ-5D-5L) - total score | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A questionnaire about quality of life in different health-related domains. | ClinicalTrials.gov |
| Primary | Change in Stroop Task - reading time | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A test assessing cognitive inhibition. | ClinicalTrials.gov |
| Primary | Change in 6 minutes walking Test (6MWT) - Distance Walked | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A test assessing walking performance; i.e., distance walked in 6 minutes. | ClinicalTrials.gov |
| Primary | Change in Timed Up and Go (TUG) test - Execution Time | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A test used to assess a person's mobility. | ClinicalTrials.gov |
| Primary | Change in 10 meters walking test (10mWT) - Execution Time | At the beginning of the treatment, at the end of the treatment (i.e., after 6 weeks), and at 45 days follow-up | A test assessing walking performance. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 7
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)